Home page
Navigation
Content
Contact
Search
+41 44 255 11 11
Emergency 24h
International Patients
Departments
Stay
Doctors & Staff
International Patients
Departments
Stay
Doctors & Staff
+41 44 255 11 11
Often searched
Test
Übersicht
Georges Mayor Lecture
Program & Speakers
Podcasts
(active)
Sponsors
Former Symposia
Interdisciplinary Uro-Oncology Symposium Zurich
Podcasts
Emergency 24h
Interdisciplinary Uro-Oncology Symposium Zurich
Übersicht
Georges Mayor Lecture
Program & Speakers
Podcasts
(active)
Sponsors
Former Symposia
Breadcrumb Navigation
Übersicht
Podcasts
Podcasts Interdisciplinary Uro-Oncology Symposium Zurich
Podcasts Symposium 2020
Prof. M. A. Rubin – Genomic testing for clinical decision making in patients with advanced prostate cancer
Prof. N. van As – Modern technologies and novel concepts of radiotherapy in 2020
Prof. H. Mostafid – Evaluation of patients with hematuria: What is the evidence for invasive investigations and imaging?
Prof. K. Hendricksen – Thermochemotherapy instillations for patients with non-muscle Invasive bladder cancer: Is there a benefit?
Prof. L. Albiges – Systemic treatment of metastatic renal cell cancer: What ist state of the art in 2020?
Prof. T. Steuber – Therapy of the metastatic hormone-sensitive prostate cancer – multimodal in the future?
Prof. K. Fizazi – Optimal treatment sequence for patients with castration-resistant prostate cancer
Podcasts Symposium 2019
Prof. D. Tilki- Salvage Options after Radical Treament of Prostate cancer – Choosing the optimal treatment for the Right Patient
Dr. A. Bex – No more cytoreductive nephrectomies for metastatic kidney cancer
Prof. M. Albersen – Are we too agressive – Penile preserving strategies for patients with penile cancer
Prof. N. Clarke – STAMPEDE – What have we learned so far and what will we learn in the future
Prof. A. Zlotta – BCG Failure in high-grade NMIBC what next
Prof. M. Galsky – Immunotherapy for bladder cancer – What is Standard and What is the future
E. Barret – Focal Therapy for Prostata cancer – What is considered State of the Art in 2019
Podcasts Symposium 2018
Prof. Haberkorn: PSMA Ligands for the Diagnosis of Prostate Cancer
Prof. Tombal: Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Are We Doing the Right Thing?
Prof. Bangma: Hereditary Genitourinary Cancers – Who Should Be Referred for Genetic Testing and How to Manage
Prof. Dieckmann: Micro-RNAs: The Better Tumor Markers for Testicular Germ Cell Tumors?
Prof. Studer: Georges Mayor Honorary Lecture: Critical Aspects Regarding the Diagnosis and Treatment of Prostate Cancer
Prof. Kulkarni: Bladder-Sparing Trimodal Therapy with Curative Intent and in the Setting of Palliation: Who Benefits and How to Do It?
Dr. Seiler: Muscle-Invasive Bladder Cancer: Selecting the Optimal Treatment for the Right Patient
Prof. Gillessen: Consensus in the Absence of Evidence: Results from the Second Advanced Prostate Cancer Consensus Conference
Prof. Haberkorn: PSMA-Targeted Radionuclide Therapy – the Next Big Player for the Treatment of Castrate Resistant Prostate Cancer?
This site is registered on
wpml.org
as a development site.